These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30900133)

  • 1. Tetrahydrocurcumin-loaded vaginal nanomicrobicide for prophylaxis of HIV/AIDS: in silico study, formulation development, and in vitro evaluation.
    Mirani A; Kundaikar H; Velhal S; Patel V; Bandivdekar A; Degani M; Patravale V
    Drug Deliv Transl Res; 2019 Aug; 9(4):828-847. PubMed ID: 30900133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Layer-by-Layer Engineered Microbicide Drug Delivery System Targeting HIV-1 gp120: Physicochemical and Biological Properties.
    Coulibaly FS; Ezoulin MJM; Purohit SS; Ayon NJ; Oyler NA; Youan BC
    Mol Pharm; 2017 Oct; 14(10):3512-3527. PubMed ID: 28830144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Phytopolyphenols for their gp120-CD4 Binding Inhibitory Properties by In Silico Molecular Modelling & In Vitro Cell Line Studies.
    Mirani A; Kundaikar H; Velhal S; Patel V; Bandivdekar A; Degani M; Patravale V
    Curr HIV Res; 2019; 17(2):102-113. PubMed ID: 31187713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study.
    Kakkar V; Kaur IP; Kaur AP; Saini K; Singh KK
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1701-1712. PubMed ID: 29938544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
    Machado A; Cunha-Reis C; Araújo F; Nunes R; Seabra V; Ferreira D; das Neves J; Sarmento B
    Acta Biomater; 2016 Oct; 44():332-40. PubMed ID: 27544812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.
    Jay JI; Lai BE; Myszka DG; Mahalingam A; Langheinrich K; Katz DF; Kiser PF
    Mol Pharm; 2010 Feb; 7(1):116-29. PubMed ID: 20014858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple combination MPT vaginal microbicide using curcumin and efavirenz loaded lactoferrin nanoparticles.
    Lakshmi YS; Kumar P; Kishore G; Bhaskar C; Kondapi AK
    Sci Rep; 2016 May; 6():25479. PubMed ID: 27151598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-sensitive dual-preventive siRNA-based nanomicrobicide reactivates autophagy and inhibits HIV infection in vaginal CD4+ cells.
    Yang S; Chen Y; Gu J; Harris A; Su RC; Ho EA
    J Control Release; 2024 Feb; 366():849-863. PubMed ID: 38176469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.
    Ham AS; Nugent ST; Peters JJ; Katz DF; Shelter CM; Dezzutti CS; Boczar AD; Buckheit KW; Buckheit RW
    Antiviral Res; 2015 Aug; 120():153-64. PubMed ID: 26093158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Safety Evaluation of HIV-1 gp120 Responsive Microbicide Delivery System in C57BL/6 Female Mice.
    Coulibaly FS; Ezoulin MJM; Dim DC; Molteni A; Youan BC
    Mol Pharm; 2019 Feb; 16(2):595-606. PubMed ID: 30525661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
    BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcuminoid-loaded poly(methyl methacrylate) nanoparticles for cancer therapy.
    Sahu A; Solanki P; Mitra S
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):101-105. PubMed ID: 29593406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-emulsifying drug delivery systems: Design of a novel vaginal delivery system for curcumin.
    Köllner S; Nardin I; Markt R; Griesser J; Prüfert F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2017 Jun; 115():268-275. PubMed ID: 28323109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of epithelial transport and oxidative stress protection of nanoengineered curcumin derivative-cyclodextrin formulation for ocular delivery.
    Maharjan P; Jin M; Kim D; Yang J; Maharjan A; Shin MC; Cho KH; Kim MS; Min KA
    Arch Pharm Res; 2019 Oct; 42(10):909-925. PubMed ID: 31030375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxymethylcellulose-tetrahydrocurcumin conjugates for colon-specific delivery of a novel anti-cancer agent, 4-amino tetrahydrocurcumin.
    Plyduang T; Lomlim L; Yuenyongsawad S; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2014 Oct; 88(2):351-60. PubMed ID: 24859389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies.
    McGowan I; Taylor DJ
    Sex Transm Dis; 2010 Jun; 37(6):361-4. PubMed ID: 20514687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S; Souto EB; Silva AM
    Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.
    Andrianov AM; Nikolaev GI; Kornoushenko YV; Xu W; Jiang S; Tuzikov AV
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31412617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.